BackReviva Pharmaceuticals Holdings Overview

Reviva Pharmaceuticals Holdings Other Current Assets

Latest other current assets for RVPH: $1.3T.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$1250.63B
277048975.01% YoYΔ $1250.63B vs prior year quarter

Peer average / median

Loading

Reviva Pharmaceuticals Holdings Other Current Assets History

Loading

Reviva Pharmaceuticals Holdings vs. peers: Other Current Assets Comparison

Loading

Reviva Pharmaceuticals Holdings Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Reviva Pharmaceuticals Holdings (RVPH) FAQ

Reviva Pharmaceuticals Holdings (RVPH) currently reports a other current assets of $1.3T as of June 2026. That compares with $450K in the prior-year period — up 277048975.0% year over year. Use the charts on this page to explore Reviva Pharmaceuticals Holdings's other current assets history and peer comparisons.

Reviva Pharmaceuticals Holdings's other current assets increased from $450K to $1.3T — a 277048975.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Reviva Pharmaceuticals Holdings reported $1.3T in other current assets as of June 2026. That compares with $450K in the prior-year period — up 277048975.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $1.3T, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Reviva Pharmaceuticals Holdings, and consider following RVPH for alerts when major investors trade the stock.

Reviva Pharmaceuticals Holdings is classified in the Healthcare sector. On other current assets, it currently shows $1.3T. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RVPH with unrelated industries.